Epi-GERD Study: Epidemiological Evaluation in Patients With Gastro-Esophageal Reflux Disease (GERD)

Study Overview
=================
Brief Summary
-----------------
Cross-sectional epidemiological study in patients with diagnosis of GERD (Gastroesophageal Reflux Disease) and with current treatment or with a history of recent treatment with some PPI (Proton Pump Inhibitor), in order to evaluate the persistence and / or relapse of symptoms of GERD.

Detailed Description
-----------------
OBJECTIVE: To carry out an evaluation about the persistence and / or relapse of symptoms in Colombian patients with diagnosis of GERD. MATERIALS AND METHODS: A multicentric cross-sectional epidemiological study will be carried out in Colombian patients with diagnosis of GERD and with current treatment or with a history of recent treatment with some PPI (Proton Pump Inhibitor). The persistence and / or relapse of symptoms will be evaluated as the main variable. The secondary variables to be evaluated include: Demographical analysis, treatment (s) used by patients, adverse events associated with the treatments, comorbidities and risk factors. The analysis will be carried out from two perspectives: A first descriptive approach and a second analytical approach, with a level of significance of 5%.

Official Title
-----------------
Epi-GERD Study: Epidemiological Evaluation in Patients With Gastro-Esophageal Reflux

Conditions
-----------------
Gastroesophageal Reflux Disease

Intervention / Treatment
-----------------
* Other: None. It is an observational study


Participation Criteria
=================
Eligibility Criteria
-----------------
Inclusion Criteria: Age ≥ 18 years Previous diagnosis of Gastroesophageal Reflux Disease (GERD) CURRENT treatment with a proton-pump inhibitor (PPI), OR NOT CURRENT treatment with some PPI but YES in the last year Exclusion Criteria: Refusal to participate in the study by the patient. Patients who, in the judgment of the Investigator, do not understand or are not willing to adequately answer to the questions. Mental or psychiatric illness that, in the judgment of the investigator, does not allow adequate information to be obtained.

Ages Eligible for Study
-----------------
Minimum Age: 18 Years

Sexes Eligible for Study
-----------------
All

Accepts Healthy Volunteers
-----------------
No

Study Plan
=================
How is the study designed?
-----------------

Arms and Interventions

| Intervention/Treatment |
| --- |
|Other: None. It is an observational study|None. It is an observational study|

What is the study measuring?
-----------------
Primary Outcome Measures

| Outcome Measure | Measure Description | Time Frame |
| --- | --- | --- |
| Symptoms of GERD (Gastroesophageal Reflux Disease) | Proportion of patients with persistence and / or relapse of symptoms of GERD. | It will be evaluated in each patient (only once, at the time of the interview) throughout the study which is estimated to last 3 years | 

Secondary Outcome Measures

| Outcome Measure | Measure Description | Time Frame |
| --- | --- | --- |
| Demographic analysis | Characterization of patients | It will be evaluated in each patient (only once, at the time of the interview) throughout the study which is estimated to last 3 years | 
| Kind of IBP taked by the patient and the way to consume it. | A descriptive analysis of the type of IBP types taken by patients and how to take them | It will be evaluated in each patient (only once, at the time of the interview) throughout the study which is estimated to last 3 years | 
| Adverse Events related with the treatments | Evaluation of Adverse events associated with the treatment (s) | It will be evaluated in each patient (only once, at the time of the interview) throughout the study which is estimated to last 3 years |